0.60 USD
↗ 0.00 (0.83%)PRE MARKET (AS OF 08:00 AM EDT)
PharmaCyte Biotech, Inc. Common Stock
PMCBNASDAQ • USD
Market: OPEN
PharmaCyte Biotech, Inc. Common Stock (PMCB) is currently trading at $0.60. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Aug 6, 2026.
Open?$0.59
High?$0.60
Low?$0.59
Prev. Close?$0.59
Volume?380
Avg. Volume?113.8K
VWAP?$0.59
Rel. Volume?0.00x
Bid / Ask
Bid?$0.50 × 100
Ask?$0.71 × 100
Spread?$0.21
Midpoint?$0.60
Valuation & Ratios
Market Cap?6.3M
Shares Out?10.7M
Float?9.5M
Float %?88.3%
P/E Ratio?N/A
P/B Ratio?0.18
EPS?-$3.59
Dividend?3.88%
Ex-Dividend?N/A
News
Profile
PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.
Employees
2
Market Cap
6.3M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2003-09-11
Address
3960 HOWARD HUGHES PARKWAY
LAS VEGAS, NV 89169
Phone: (917) 595.2850
LAS VEGAS, NV 89169
Phone: (917) 595.2850
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?69
Piotroski F-Score?0/9Weak
Altman Z-Score?-2.59Distress
Confidence?44%Low
Short InterestModerate
Short % of Float?3.40%Low
Short Interest?322.4K
Days to Cover?4.3
Free Float9.5M
Avg Daily Volume75.8K
Settlement Date2026-07-15
Financial Health
Current Ratio?45.28Strong
Quick Ratio?45.28Strong
Cash Ratio?22.51Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.18CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?1.4CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-111.4%WEAK▾
S&P3
ROA?-82.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$-12269866
Fundamentals ratios updated end of day